Insider Transactions in Q4 2022 at Kronos Bio, Inc. (KRON)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 12
2022
|
Christopher Dinsmore Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
9,138
-5.31%
|
$9,138
$1.81 P/Share
|
Dec 12
2022
|
Jorge Di Martino Chief Medical Officer & VP |
SELL
Open market or private sale
|
Direct |
18,657
-7.83%
|
$18,657
$1.81 P/Share
|